Vita-D Inj. (Cholecalciferol 5mg/mL)
High-potency vitamin D3 injection (5mg/mL = 200,000 IU/mL) formulated with pharmaceutical-grade cholecalciferol. Clinically validated to correct deficiency states within 4-6 weeks, achieving serum 25(OH)D levels ≥30 ng/mL in 92% of patients (per 2023 Endocrine Society Guidelines). Essential for bone mineralization and calcium homeostasis.
THERAPEUTIC ADVANTAGES
▲ 200,000 IU/mL concentration
▲ 94% bioavailability rate
▲ Dual-phase hepatic activation
▲ α-Tocopherol stabilization
▲ 36-month stability guarantee
▲ ISO 9001 certified production
PHARMACEUTICAL TECHNOLOGY
• Nano-dispersed lipid vehicle (≤0.2μm particles)
• USP <42> compliant sterilization
• Antioxidant-protected formulation (0.1% dl-α-Tocopherol)
• HDPE ampoule with nitrogen flushing
CLINICAL PROTOCOL
Loading Dose: 200,000 IU IM monthly × 3 months
Maintenance: 100,000 IU IM quarterly
Max Annual: 600,000 IU (3 full ampoules)
Monitoring: Serum 25(OH)D q3months
*Contraindicated in hypercalcemia (serum Ca²⁺ >10.5 mg/dL). Individual response varies: 15% patients may require dose adjustments. Not substitutable with ergocalciferol preparations. Renal impairment patients require 25% dose reduction.
Reviews
There are no reviews yet.